| Virginia Family Integrated Medicine | |
|
5130 Duke St Ste 114, Alexandria, VA 22304-2924 | |
| (703) 370-5300 | |
| (703) 370-0080 |
| Full Name | Virginia Family Integrated Medicine |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner |
| Location | 5130 Duke St Ste 114, Alexandria, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780840413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Secondary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Virginia Family Integrated Medicine 344 Maple Ave West, 231, Vienna, VA 22180 Ph: (703) 370-5300 | Virginia Family Integrated Medicine 5130 Duke St Ste 114, Alexandria, VA 22304-2924 Ph: (703) 370-5300 |
News Archive
Research from the USA shows that a substantial proportion of obese patients are prescribed bronchodilators, even after spirometry indicates a lack of lung obstruction.
Two Cedars-Sinai physician-researchers have been awarded grants totaling $4 million from the National Institutes of Health to study how the environment - both in the womb and in the hospital where the baby is born - can affect the newborn and the mother.
1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.
People living in predominately Hispanic neighborhoods are less likely to receive CPR from a bystander following an out-of-hospital cardiac arrest compared to people living in non-Hispanic neighborhoods, researchers from Penn Medicine and the Duke University of School of Medicine reported in the journal Circulation.
Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.
› Verified 6 days ago